Every SEC Form 3/4/5 on record for this filer (CIK 1735397) — 8 issuers, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | 10% owner · lapsed | 2022-01-10 → 2022-01-10 | 1 | — |
| XLO | Xilio Therapeutics, Inc. | 10% owner · lapsed | 2021-10-21 → 2021-10-26 | 2 | — |
| THRX | Theseus Pharmaceuticals, Inc. | 10% owner · lapsed | 2021-10-06 → 2021-10-14 | 2 | $4M |
| VERV | Verve Therapeutics, Inc. | 10% owner · lapsed | 2021-06-16 → 2021-06-22 | 2 | — |
| AVIR | Atea Pharmaceuticals, Inc. | 10% owner · lapsed | 2020-10-29 → 2020-11-04 | 2 | — |
| INZY | Inozyme Pharma, Inc. | 10% owner · lapsed | 2020-07-23 → 2020-07-28 | 2 | $10M |
| IMRA | IMARA Inc. | 10% owner · lapsed | 2020-03-11 → 2020-03-16 | 2 | $4M |
| FIXX | Homology Medicines, Inc. | 10% owner · lapsed | 2018-03-27 → 2018-04-04 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| THRX | 2021-10-12 | Buy | 250,000 | $16.00 | $4M | 599,320 |
| INZY | 2020-07-28 | Buy | 24,000 | $16.00 | $384,000 | 1,067,884 |
| INZY | 2020-07-28 | Buy | 576,000 | $16.00 | $9M | 1,043,884 |
| IMRA | 2020-03-16 | Buy | 250,000 | $16.00 | $4M | 523,411 |
3 of 8 issuers are covered and open a security page; the rest are on file here only.
